<DOC>
	<DOCNO>NCT02053363</DOCNO>
	<brief_summary>The purpose study evaluate two dosing protocol tranexamic acid ( TXA ) , anti-fibrinolytic used decrease blood loss adult patient undergo complex , reconstructive spinal fusion surgery .</brief_summary>
	<brief_title>Tranexamic Acid Dosing Adult Spinal Deformity Surgery</brief_title>
	<detailed_description>After consent obtain patient enrol trial , patient assign de-identified , unique identification ( ID ) number . Randomization IDs either low high dose TXA occur via computer generate random assignment . Given variation may exist surgical technique ( e.g . performance osteotomy ) , stratify randomization perform attend surgeon . Based upon randomization , pharmacy prepare TXA one two intravenous dose protocol : 1 . Low Dose ( Standard Care/Control ) : Loading Dose 10mg/kg give 15 minute , follow 1mg/kg/hr via continuous infusion 2 . High Dose ( Study Group ) : Loading Dose 50mg/kg give 15 minute , follow 5mg/kg/hr via continuous infusion . The surgeon , anesthesia team , operate room staff blind concentration TXA medication receive . Treatments may `` unblinded '' discretion surgeon anesthesiologist , case extreme blood loss . If additional anti-fibrinolytics give , change dose record . Post-operative care patient data collection information contain patient 's medical record part routine , standard care .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Adult patient ( age 1875 ) schedule undergo long segment ( great 8 motion segment ) posterior spinal fusion instrumentation ( PSF ) adult scoliosis Patients acquire defective color vision Subarachnoid hemorrhage Active intravascular clot Hypersensitivity tranexamic acid ingredient Patients predonate autologous blood intra postoperative use ( Directed donor unit acceptable ) History suspect blood disorder abnormal coagulation laboratory result Current anticoagulation therapy interrupt History deep vein thrombosis ( DVT ) Impaired renal function creatinine clearance &lt; 60 ml/min Pregnancy woman lactating/breastfeeding Women hormonal contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>tranexamic acid , reconstructive spine surgery</keyword>
</DOC>